15. 29
เอกสารอ้างอิง
1. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected
musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778 - 799.
2. Davatchi F. Special article: Rheumatic disease in APLAR region. APLAR J Rheumatol 2006;9:5 - 10.
3. Weir PT, Harlan GA, Nkoy FL, et al. The incidence of fibromyalgia and it associated comorbidities:
a population-based retrospective cohort study based on International Classification of Diseases, 9th
Revision codes. J Clin Rheumatol 2006;12:124 - 128.
4. Mense P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures,
and treatment. J Rheumatol Suppl 2005;75:6 - 21.
5. Yunus MB. The concept of central sensitivity Syndromes. In: Fibromyalgia & Other Central Pain
Syndromes. Wallace DJ, Clauw DJ. Ed Lippincott Williams & Wilkins 2005;29 - 44.
6. Buskila D, Sarzi-Puttini P, Ablin JN. The genetic of fibromyalgia syndrome. Pharmacogenomics
2007;8:67 - 74.
7. Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: the pathophysiology of
fibromyalgia. Ann Intern Med 2007;146:726 - 34.
8. Borg-Stein J. Management of peripheral pain generators in fibromyalgia. Rheum Dis Clin North Am
2002;28:305 - 317.
9. Bradly LA, Alarcon GS. Psychological factors in fibromyalgia. In: Fibromyalgia & Other Central Pain
Syndromes. Wallace DJ, Clauw DJ. Ed Lippincott Williams & Wilkins 2005;165 - 176.
10. Cronje R. Evidence-based medicine: Toward a new definition of “Rational Medicine”. Health.
2003;7:353 - 369.
11. Wolfe F, Smythe HA, Yunus MB, et al. The American Colleague of Rheumatology 1990 criteria
for the classification of fibromyalgia. Arthritis Rheum 1990;33:160 - 172.
12. Yunus M, Masi AT, Calabro JJ, et al. Primary fibromyalgia (fibrositis): clinical study of 50 patients
with matched normal controls. Semi Arthritis Rheum 1981;11:151 - 170.
13. Bennett R, Nelson D. Cognitive behavioral therapy for fibromyalgia. Nature Clin Practice
Rheumatol 2006;2:416 - 424.
14. Berger A, Dukes E, Martin S, Edelsberg J, Oster G.Characteristics and healthcare costs of patients
with fibromyalgia syndrome. Int J Clin Pract. 2007;61:1498 - 1508.
15. Stein JB, Simons DG. Focus review myofascial pain. Arch Phys Med Rehabil 2002;83 Suppl 1:
40 - 48.
16. 30
แนวทางเวชปฏิบัติ กลุ่มอาการปวดเรื้อรังระบบกระดูกและกล้ามเนื้อ
16. Wolfe F, Simons DG, Friction J, et al. The fibromyalgia and myofascial pain syndrome: a
preliminary study of tender points and trigger points in person with fibromyalgia, myofascial pain,
and no disease. J Rheumatol 1992;19:944 - 951.
17. Update on Fibromyalgia Syndrome. Pain Clinical Updates (IASP), Volume XVI, Issue 4, June 2008.
18. Alpay M. Pain patients. In : Stern T, Friechione GL, et al. General Hospital Handbook of General
Hospital Psychiatry, 5th
ed. Philadelphia, Elsevier, 2004.
19. Häuser W, Bernardy K, Uçeyler N, Sommer C. Treatment of fibromyalgia syndrome with antidepre
ssants: a meta-analysis. JAMA 2009;301:198 - 209.
20. Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP Jr, Sharma U, Martin SA, Barrett JA, Haig G.
A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in
patients with fibromyalgia. J Pain 2008;9:792 - 805.
21. Crofford LJ, Mease PJ, Simpson SL, Young JP Jr, Martin SA, Haig GM, Sharma U. Fibromyalgia
relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-
blind, placebo-controlled trial with pregabalin. Pain 2008;136:419 - 31.
22. Mease PJ, Russell IJ, Arnold LM, Florian H, Young JP Jr, Martin SA, Sharma U. A randomized,
double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with
fibromyalgia. J Rheumatol 2008;35:502 - 14.
23. Arnold LM, Crofford LJ, Martin SA, Young JP, Sharma U. The effect of anxiety and depression on
improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia.
Pain Med 2007;8:633 - 8.
24. Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, Young JP Jr,
LaMoreaux LK, Martin SA, Sharma U; Pregabalin 1008-105 Study Group. Pregabalin for the
treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.
Arthritis Rheum 2005;52:1264 - 73.
25. Arnold LM, Goldenberg DL, Stanford SB, Lalonde JK, Sandhu HS, Keck PE Jr, Welge JA, Bishop
F, Stanford KE, Hess EV, Hudson JI. Gabapentin in the treatment of fibromyalgia: a randomized,
double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 2007;56:1336 - 44.
26. Bennett RM, Schein J, Kosinski MR, Hewitt DJ, Jordan DM, Rosenthal NR. Impact of fibromyalgia
pain on health-related quality of life before and after treatment with tramadol/acetaminophen.
Arthritis Rheum 2005 15;53:519 - 27.
27. Russell IJ, Kamin M, Bennett RM, Schnitzer TJ, Green JA, Katz WA. Efficacy of Tramadol in
Treatment of Pain in Fibromyalgia. J Clin Rheumatol. 2000;6:250 - 257.
17. 31
28. Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in
the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J
Med 2003;114:537 - 45.
29. Sayar K, Aksu G, Ak I, Tosun M. Venlafaxine treatment of fibromyalgia. Ann Pharmacother
2003;37:1561 - 5.
30. Samborski W, Lezanska-Szpera M, Rybakowski JK. Open trial of mirtazapine in patients with
fibromyalgia. Pharmacopsychiatry 2004;37:168 - 70.
31. Nakamahachalasint P. Genetic polymorphisms and CYP2D6 activity in Thai subjects.
Pharmaceutical science, [thesis]: Bangkok: Chulalongkorn University. 2003.
32. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA
2004;292:2388 - 2395.
33. Granges G, Zilko P, Littlejohn GO. Fibromyalgia syndrome : assessment of the severity of the
condition 2 years after diagnosis. J Rheumatol. 1994;21:523 - 29.
34. Goldenberg : Report in 1st
International Scientific Forum on Fibromyalgia. Athens, Greece, 18 - 20
september, 2008.